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“Life is not about how fast you run or how high you climb but how well you bounce.”  
























“…we know that it is the search that gives meaning to any find and that one often has to 




As the world population is growing older and more sedentary every day, the need for new 
approaches to combat chronic diseases grows steadily. Physical exercise improves health and 
reduces the risk of developing a plethora of chronic diseases. This body of work aims to 
investigate the molecular mechanisms underlying the neuronal and muscle function, their 
interaction and the potential signals that mediate this communication.  
To gain more insight into neurodegeneration, in paper I, we used a mouse model of 
Alzheimer’s disease and examined the mechanisms generating amyloid plaques. We 
discovered that Presenilin 1 (PS1), the key player of the enzyme responsible for generating 
the pathogenic peptides that make up the plaques, can play a dual role. Upon phosphorylation 
at a specific site, PS1 can facilitate the degradation of the substrate that would otherwise be 
cleaved to generate toxic amyloid peptides. This function ultimately reduces soluble amyloid 
peptide levels as well as the plaque burden. Overall this study extends our understanding of 
neurodegenerative processes and proposes a new target for intervention. 
In paper II, we investigated the transcriptional signatures of inherent and acquired exercise 
capacity in the skeletal muscle using uniquely developed rodent models. Our results associate 
high exercise capacity with angiogenesis and oxygenation while low exercise capacity profile 
reflects gene programs related to inflammation and cardiovascular disease. We interrogated 
the transcriptome data for potential upstream regulators and also secreted factors that can 
mediate exercise capacity and response. Finally, we compared the rat transcriptomic 
signatures with those of humans and identified an overlapping set of genes.  
In paper III, we explored the biological function of a muscle-secreted factor called Neurturin 
(NRTN). Transgenic animals overexpressing NRTN in skeletal muscle are leaner and more 
glucose tolerant than controls. Their muscles exhibit increased oxidative metabolism and 
vascularization. We observed a NRTN-induced remodelling in neuromuscular junction 
morphology and discovered that NRTN can promote a slow motor neuron identity and reduce 
markers for fast-motor neurons. Functionally, muscle-specific overexpression of NRTN 
enhances endurance performance and improves motor coordination. Systemic delivery at the 
adult stage could achieve an improvement in glucose metabolism and also recapitulate the 
improved motor coordination. We propose NRTN as a myokine with therapeutic promise for 
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Living longer and better has been a centuries-old goal for humankind. As much as the human 
imagination allowed, this goal rested on the shoulder of myths and plant-based potions, being 
rather unattainable until the 19th century. The advent of sanitation and healthcare practice 
allowed historic extensions of life expectancy for the majority of the population. This stride, 
accompanied by technological advances, brought new challenges associated with pushing the 
boundaries of human longevity. According to the World Health Organisation (WHO), the 
European median age is the highest in the world; with the proportion of people aged over 65 
is forecast to double in 2050. As we live longer, the chances of spending this time in good 
health are decreasing in parallel. Increasingly sedentary lifestyles and unhealthy diet have led 
to a high incidence of obesity, metabolic dysfunction and associated complications. 
Worldwide, type 2 diabetes alone claims more than 3 million lives annually. Alongside, the 
prevalence of major neurological disorders is on the rise with cerebrovascular diseases being 
the leading cause of death among them and dementia the second (1, 2). In addition, age-
related muscle atrophy impairs physical activity leading to additional co-morbidities. These 
challenges expose the limits of our current therapeutic toolbox and necessitate novel 
approaches to mitigate disease and increase the quality of life.   
It is well known that physical exercise improves health and reduces the risk of premature 
mortality (3, 4). Regular exercise stimulates a multi-organ cross-talk that benefits a variety 
of systems leading to an improvement in health. Arguably, exercise is one of the most 
effective strategies to attenuate metabolic dysfunction and age-related health decline. 
Understanding the mechanisms and systemic factors that mediate exercise benefits and how 
they are regulated could provide clues to develop new approaches to fight disease. 
From anatomical analysis by Vesalius to cell level by Virchow and molecular resolution by 
Sterling & Bayliss, our approach to understanding biology has been an effort to zoom in. 
Advances in technology carried this evolution further and enabled an unprecedented level of 
resolution with tools like the single-cell sequencing and expansion microscopy. Still, 
zooming in doesn’t always lead to clear views and may confine our perception. Equally 
important is to keep in sight and evaluate systemic connections, to zoom out.  
Here, I present my scientific efforts to take a broad overlook at the molecular mechanisms 
underlying the decline in neuronal and muscle function and position exercise-induced 







2 SYSTEMIC EFFECTS OF AGING AND PHYSICAL 
INACTIVITY 
The modern world has become an increasingly convenient place that revolutionized our 
lifestyle. Progressive innovation reshaped what it means “to work” as machine power 
replaced manpower and the digital world emulated the physical world to the extent of 
replacing it in certain aspects. The traditional approach to social life, transport and labor are 
increasingly replaced with contemporary ones that involve electronic devices and fiberoptic 
cables. As a result, human behavior has been, and continues to be, modified tremendously. 
Even though the technological means allowed us to develop more resilience against threats 
from predators and spared us from starving due to limited food availability, the drastic 
changes in modern life led to a more sedentary lifestyle. This, in turn, led to increased 
incidence of chronic diseases including cardiovascular diseases, metabolic disorders (e.g 
diabetes, obesity, metabolic syndrome) and neurological disorders such as Alzheimer’s 
disease (5). Today, diabetes is among the leading causes of death in the world and excess 
weight and obesity kills more people than malnourishment(6). The global burden of 
neurological disorders also keeps growing and around 50 million people live with a form of 
dementia, a number set to triple by 2050(7). 
Physical inactivity is a major risk factor for many chronic pathologies, including those 
mentioned before, and has also been shown to exacerbate the morbidity and mortality rates 
(3, 4, 8). In addition, a growing body of evidence links sedentary overindulgent lifestyles and 
resulting metabolic alterations to accelerated brain aging and neurodegeneration (9, 10). 
The pathological mechanisms triggered by physical inactivity and aging are subjects of 
extensive research and systemic factors likely play a considerable part in linking inactivity 
and chronic disease. 
2.1  METABOLIC DYSFUNCTION 
In the modern world, prevalent physical inactivity combined with almost infinite caloric 
supply leads to a rise in the incidence of metabolic diseases at a tremendous pace. Today, 
obesity and associated diseases pose a real threat to public health as in the past few decades, 
the prevalence of obesity almost tripled in Europe alone and continues to increase worldwide 
at an alarming rate. Based on the latest estimates by WHO, in 2016, around 1.9 billion adults 
were overweight and among these 650 million people were obese, corresponding to 13% of 
the entire human population (Figure 1). The prevalence among children and adolescents is 
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even more alarming. As of 2019, the number of overweight or obese children under the age 
of 5 is reported as 38 million. Developed countries seem to have the largest share in the global 
obesity epidemic. In the USA alone, the prevalence of obesity is around 30%, tailed by the 
European union with roughly 20% of people obese. This is closely reflected by the Swedish 
population with 22% of the adult population considered obese in the 2016 WHO report.
 
Figure 1: Share of adults that are obese from 1975 to 2016 (11). Individuals with body Mass Index (BMI) 
25 or higher is considered overweight while BMI greater than 30 is defined as obesity.  
Obesity commonly co-exists with type-2 diabetes, dyslipidemia, and hypertension (12). 
Additionally, it is associated with a wide range of pathologies from fatty liver to cancer and 
Alzheimer’s disease. From an evolutionary perspective, humans transitioned from the 
environment with limited food availability to infinite access to food in a relatively short time. 
Therefore, biological adaptations to scarcity in the form of storing excess energy now may 
have been working against the overabundant and sedentary lives of our times. In essence, 
obesity is a result of energy imbalance due to excess food intake that far exceeds the energetic 
demands of the body. This extra energy is primarily stored in white adipose tissue depots 
throughout the body in the form of lipids. If the excess energy intake continues and fills the 
adipose tissue capacity, it spills over to other tissues. This ectopic fat accumulation is linked 
to additional pathologies such as mitochondrial dysfunction and systemic inflammation (13). 
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2.1.1 Type-2 Diabetes  
There is broad consensus on the strong association between obesity, insulin resistance and 
type 2 diabetes. The WHO estimates point to obesity and excess weight (BMI over 25 kg/m2) 
as the underlying factor for approximately 70% of new diagnoses for type 2 diabetes. Thus, 
in parallel with obesity, the prevalence of type 2 diabetes is also increasing at alarming rates. 
Based on the most recent epidemiological data, as much as 463 million adults are estimated 
to have diabetes worldwide and half of them go undiagnosed (14). If the current trends 
continue, this number is projected to reach 700 million by 2045. Moreover, diabetes 
prevalence seems to increase with age, as the 65-99-year-old group represent 20% of people 
with diabetes. With a rapidly aging population, the world will have to face the inevitable 
challenges in many fronts including economic and public health consequences.  
The defining feature of diabetes is impaired glucose homeostasis. Therefore, to fully 
understand type 2 diabetes, it is crucial to have an insight into the glucose metabolism. 
Glucose metabolism 
Blood glucose increases after food consumption and triggers the signals to stimulate glucose 
uptake and storage or utilization. One of these signals is insulin which targets liver, skeletal 
muscle and adipose tissue but it can affect a variety of cells and tissues (15). The control of 
blood glucose levels by insulin serves to ensure efficient energy storage and regulation of 
energy metabolism in multiple tissues. To achieve this, insulin signals through a complex 
network with multiple nodes and controls several cellular processes. From a very simplistic 
point of view, upon insulin binding, the insulin receptor activates insulin receptor substrates 
(IRS) which then relays the signal to multiple downstream effectors. The main components 
of this network are the phosphoinositide 3 - kinase (PI3K)/protein kinase B (PKB/AKT) 
pathway and the Ras–mitogen-activated protein kinase (MAPK) pathway (16). Once 
activated, the PI3K-AKT pathway orchestrates most of the metabolic response and enables 
cells to properly handle the elevated glucose levels in circulation (this ability is often termed 
glucose tolerance). For example, increased glucose uptake through promoting translocation 
of glucose transporter (GLUT) to the cell membrane and storage in the form of triglycerides 
in adipose tissue or glycogen in skeletal muscle and liver.  
Failure to trigger the response to elevated glucose levels (hyperglycemia) results in metabolic 
dysfunction and in time builds up glucose intolerance, together with increased insulin levels 
(hyperinsulinemia)(16). In such conditions, insulin sensitivity of target tissues progressively 
declines, eventually building up insulin resistance. If not managed properly, hyperglycemia 
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and insulin resistance can lead to life-threatening complications linked to metabolic 
dysfunction, such as cardiovascular disorders and may even lead to neurodegeneration.  
2.2 NEURODEGENERATION 
Physical inactivity and increased energy intake are proposed to reduce the ability of the 
adaptiveness of the brain to energetic challenges and result in failure to keep optimal brain 
function and render it vulnerable to disease (17–20). During aging, together with other 
systems, our brain function also declines in multiple ways including impairments in 
cognition, motor coordination and neuroplasticity (18, 21, 22). Although cell-intrinsic 
changes may explain the decline in brain function to a certain extent, accumulating evidence 
indicates that systemic, metabolic changes likely play an important role in the initiation and 
progression of the functional decline of the brain (18).  
Figure 2: Progression of physiological, cognitive and motor changes in neurodegenerative disorders, from 
Ahmed, R. M. et al. (2018), reprinted with permission (23).   
Pathological protein aggregation, mitochondrial dysfunction, gliosis, vascular damage and 
autophagic dysfunction are among the mechanistic similarities of several predominant 
neurodegenerative diseases (including Parkinson’s disease, AD and other types of dementia, 
and ALS) (23–26). Clinical and epidemiological data suggests that physiological changes, 
including metabolic changes, predate the motor and cognitive dysfunction by about 5 years 
in several prevalent neurodegenerative diseases (Figure 2) (23). Early studies on the brains 
of dementia patients suggested impaired glucose and oxidative metabolism (27). Likewise, 
longitudinal studies indicate that metabolic disorders obesity, diabetes and atherosclerosis 
are predisposing factors for dementia (28–30). Furthermore, cerebrovascular changes have 
been associated with developing dementia, with supporting evidence showing blood-brain 
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barrier (BBB) breakdown in AD brains (31–34). In line with this, non-invasive brain imaging 
suggests that age is negatively correlated with cerebral blood flow (35) as well as BBB 
integrity (36) in humans. Reduced blood flow and can lead to impaired energy metabolism 
in the brain due to reduced delivery of nutrients as well as other circulatory factors that might 
be neuroprotective. Supporting evidence obtained using animal models shows reduced 
glucose transporters in the aged brain (37) and remarkably, old animals display a reversal of 
the age-related cerebrovascular and cognitive dysfunction when exposed to factors in young 
blood (38). Additionally, compromised BBB may promote penetration of aggregate-prone 
proteins and inflammatory agents from circulation (39–41).  
Taken together, these and other findings mount a compelling case for the involvement of 
systemic factors related to energy metabolism or inter-organ communication at the onset or 
progression of neurodegeneration (41, 42). Evaluating neurodegenerative diseases as 
systemic multifactorial syndromes and understanding the physiological changes during the 
disease continuum could help finding early windows of opportunity for intervention before 
the functional deterioration.  
2.2.1 Dementia and Alzheimer’s Disease 
Dementia is one of the greatest burdens of neurodegeneration and it is characterized by 
progressive loss of memory and cognitive abilities. Although the major risk factor for 
dementia is aging, it is not an inevitable consequence of aging, rather a pathological 
syndrome that poses a real threat to public health with serious societal and economic 
implications (43). As the world population is rapidly aging, the incidence of dementia has 
also been on the rise. Currently, WHO estimates indicate that worldwide 50 million people 
live with dementia and project a rise to 152 million people by 2050.  
The most prevalent form of dementia is Alzheimer’s Disease (AD), representing around 60-
70% of cases. Commonly, sporadic AD patients develop a late-onset disease, past age 65, 
while the rare familial form of the disease can manifest itself at as early as 30 years old and 
progress rapidly (44, 45). Patients exhibit a variety of symptoms and because there is no 
reliable diagnostic tool yet, physicians rely on these progressive symptoms for clinical 
diagnosis (45, 46). Initial stages of the disease typically involve memory problems, confusion 
and difficulties in concentration, and later on progress to severe memory deficits, motor 
dysfunction, mood swings and other cognitive and behavioral impairments. Late stages of 
the disease place a heavy burden on the caregivers to aid the patients in physical activities of 
daily life as well as to manage mental health (47). The caregiving and medical costs are part 
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of the challenge the society has to tackle considering the increasing prevalence of AD 
worldwide.   
Given the lack of an effective treatment and the dire predictions for the spread of the disease, 
the need for an improved understanding of the disease pathology is evident.  
2.2.2 Pathophysiology of Alzheimer’s Disease  
Characteristically, AD brains contain aggregated amyloid plaques composed of amyloid β 
(Aβ) peptide and the neurofibrillary tangles formed by tau protein (45, 48). Accompanying 
these, vascular damage, neuronal loss, gliosis, oxidative damage, neuroinflammation, 
mitochondrial and autophagic dysfunction are among the other hallmarks AD pathology (45). 
There are different theories about what triggers the disease and one of them, the amyloid 
cascade hypothesis, places Aβ pathology upstream of other pathologies (48, 49). Other 
prominent theories propose alternatives such as neurofibrillary tangles, vascular damage, 
inflammatory cues, or a combination of concomitant factors (50–52). While the discussion is 
ongoing, the consensus point around this issue seems to be that AD is a multifactorial disease 
involving a wide range of pathologies.   
Genetic mutations that cause increased Aβ production, plaque burden, neuronal dysfunction 
and memory impairments form the basis for the ongoing investigation into amyloid 
metabolism. Compelling evidence indicate that the progression of AD mirrors other 
neurodegenerative diseases which involve physiological changes before the first clinical 
symptoms appear(23, 50). Accordingly, in the context of this thesis, the focus points will be 
some of the events that are upstream of the Aβ plaque formation.   
Much attention has been directed at the mechanism of Aβ production through APP (Amyloid 
precursor protein) processing (Figure 3). As a substrate, APP processing leads to toxic Aβ 
production through amyloidogenic pathway (53). The initial cleavage is executed by β-
secretase enzyme leading to a soluble form of APP and β-CTF. Next, β-CTF is further 
cleaved by γ-secretase to generate the toxic Aβ peptides. These insoluble Aβ monomers 
accumulate and form neurotoxic Aβ fibrils which are deposited as extracellular plaques. 
Some evidence suggests that intraneuronal Aβ accumulation precedes the formation of the 




Figure 3: APP processing: The nonamyloidogenic processing starts with α-secretase cleavage which creates a 
soluble APPα peptide and a C-terminal fragment attached to the membrane (α CTF) and ends with final γ-
secretase cleavage of αCTF into smaller and non-toxic fragments P3 and AICD. On the contrary, amyloidogenic 
processing contains sequential cleavage by β-secretase and γ-secretase generating aggregate-prone Aβ 
monomers and AICD. (From O’Brian, Wong, Annual Rev. Neuro., 2011, reprinted with permission)(55).  
The multiprotein enzyme complex γ-secretase has a central role in APP processing and 
familial early-onset AD pathology (44, 56–59). Different mutations in its catalytic subunit 
presenilin 1 (PS1), its isoform presenilin 2 (PS2), and substrate amyloid precursor protein 
(APP) has been shown to lead to early pathological Aβ plaque load and cognitive dysfunction 
due to toxic Aβ peptide accumulation. To date, population genetics studies identified nearly 
300 mutations in PS1 alone, affecting the pathology to varying degrees and some of these 
mutations served as indispensable tools to generate research models to study (60).  
Currently, there is no available therapy for AD and despite the long history of the disease, 
drug development remains nascent with some symptomatic relief. Therefore, there is 
considerable attention to find new ways and identify new factors that could affect pre-onset 
pathological changes. Among the emerging areas, this thesis will explore the involvement of 
autophagic dysfunction and impaired glucose metabolism.  
Autophagic dysfunction in Alzheimer’s Disease 
Many neurodegenerative diseases that affect humans are associated with accumulation and 
aggregation of proteins in neurons and a number of them with mitochondrial dysfunction (26, 
61). Autophagy plays an essential role in cellular homeostasis through the turnover of old or 
dysfunctional peptides, proteins, protein-aggregates and even organelles (62). In healthy 
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neurons, autophagy is constitutively active and works quite efficiently (63). Thus, the role of 
autophagy in neuronal dysfunction and neurodegeneration has been studied extensively in 
the past decades (64–68). Of these, several studies suggested that autophagy and 
endolysosomal pathway may play a role in Aβ metabolism and APP trafficking (69–74). 
Cataldo et al. were the first to show accumulated autolysosomes in post-mortem brain 
samples from AD patients using electron microscopy (71). Later on, more evidence 
demonstrated that immature autophagic vesicles accumulate in the degenerating neurons of 
AD patients (63, 75–79). These observations suggest that autophagy is involved in disease 
progression and subsequent Aβ aggregation. In support, reduction in autophagic activity 
correlates with aging, where aggregate-prone proteins similar to Aβ can cause dementia and 
cognitive dysfunction (80).  
Impaired Glucose Metabolism in AD  
Epidemiological studies indicate that type 2 diabetes is a risk factor for AD as diabetes 
patients have doubled chance of developing AD (81, 82). Longitudinal studies also provide 
additional evidence for this strong association and also suggest that diabetic patients show a 
worse disease progression than age-matched heathy people (83–86). In addition, 
neuroimaging of diabetic patients revealed structural changes similar to AD patients, in 
particular brain atrophy in the same regions (87–89). Perhaps more interestingly, diabetes 
patients display an impaired amyloid metabolism in pancreas (90). Furthermore, synaptic, 
mitochondrial and autophagic dysfunction are also among the pathologies common to AD 
and diabetes (91). Based on the data showing defective brain insulin signaling and glucose 
uptake in AD (92, 93), some researchers even proposed that AD is a type of diabetes (94). 
Although the jury is still out on this particular issue, a considerable amount of data suggest 
that hyperglycemia and insulin resistance could have detrimental effects in the brain, such as 
synapse loss, autophagic malfunction and neuronal death (93, 95, 96). Ultimately, these may 
trigger further dysfunction in Aβ metabolism and lead to AD pathology. More insight into 
the ways to fine-tune cellular and systemic metabolic function could provide new strategies 







3 EXERCISE AS AN INTERVENTION 
“Eat less. Move more.” This simple mantra for health dates as far back as to Hippocrates, 
built on the long history of physical activity from Ancient Greeks and Romans. This 
seemingly rudimentary approach remains valid, perhaps today more than ever, with a 
pandemic blanketing all areas of our lives, lest our mobility. Naturally, the body adapts itself 
to physical inactivity but with serious consequences such as lower bone mineral density, loss 
of muscle mass and elevated blood pressure. Over time this leads to a lower functional 
capacity and a shorter lifespan. Indeed, physical inactivity contributes to a myriad of chronic 
diseases, including cardiovascular diseases, diabetes, obesity and even certain types of cancer 
and dementia (4, 5, 97). In addition, low exercise capacity is a predictive factor for premature 
mortality (3, 4). The other side of the coin is regular exercise which can act as a preventive 
factor for over 30 chronic diseases with its diverse health benefits (5). Moreover, besides 
being a preventive factor, exercise is prescribed as a therapy for many diseases (98, 99).   
3.1 EXERCISE CAPACITY AND RESPONSE  
Exercise is viewed as both primary prevention strategy and a disease intervention for chronic 
diseases (98). There is considerable focus on the value of exercise as an intervention after the 
disease onset where the aim is to prevent further decline in functional capacity, if not restore. 
An example of this is cardiac rehabilitation following a myocardial infarction which benefits 
the patient’s health but cannot reverse the anatomic pathology (100). As a prevention 
strategy, exercise fosters general well-being which decreases the possibility of developing  
chronic diseases and thereby reduces overall mortality rates (3, 4). Perhaps, this is the most 
effective way to spread the benefits of exercise far and wide. However, not all people have 
the ability to perform the daily required amount of exercise due to lack of access or 
debilitating diseases (101, 102). Patients suffering from neuromuscular disorders, morbidly 
obese or bed-ridden lack the conditions to meet the daily exercise requirements. Some people, 
even though they can exercise, cannot gain as much from it because of the inherent variability 
in exercise capacity (103–105). 
The outcomes of exercise training in terms of physiological adaptation are highly 
heterogeneous even in homogeneous groups with similar physiological traits such as weight, 
age, gender and fitness level. Underlying reasons for this are multi-layered and linked to the 
complexity of exercise capacity as a physiological trait. Both genetic and environmental 
factors contribute to exercise capacity and these factors can separately explain up to 50% of 
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the variance in humans (106, 107). Moreover, the inheritable factors at play can be classified 
as intrinsic which operates at sedentary state, and adaptive which is acquired through training 
and can be described as exercise response. The HEalth, RIsk factors, exercise Training, And 
GEnetics (HERITAGE) Family Study, designed to dissect the effects of genetic and 
environmental factors on exercise capacity, provided evidence that there is strong familial 
inheritance in response to aerobic exercise in humans (103, 105, 106, 108).  The response 
rate in terms of gains in maximal oxygen consumption ranged from 0 to 100% with nearly 
20% of participants showing little to no change. Although it is evident that this high variance 
entails a strong genetic component, the underlying factors to responsiveness to aerobic 
exercise remain largely unknown. 
The efforts to unravel the mechanisms that can improve our understanding of the link 
between exercise capacity and disease risk lacked accurate modelling until recently (109–
111). Chemical-based models are often artificial interventions and gene-targeted models of 
inbred animals may not fully reflect polygenic, complex diseases including cardiovascular 
disease, diabetes and neurodegenerative diseases (112). In the early 2000s, new models 
emerged to study the intrinsic and response phenotypes and research into dissecting their 
roles and underlying molecular mechanisms have gained more momentum (109, 111, 113–
115).  
Increasing exercise capacity with exercise training is strongly associated with lower mortality 
rates from all causes(3). Given the variability in responsiveness to exercise and considering 
the limitations to exercising, finding ways to recapitulate the exercise effect with 
pharmaceutical intervention attracts considerable interest. In reality, mimicking exercise is 
no simple beat. Not least considering the variety of adaptations most of which depend on the 
type, duration and intensity of the exercise (116, 117). Plus, the health benefit of exercise in 
its entirety is too complex to be mimicked in a drug. Nonetheless, individual aspects of it can 
be harnessed to develop ways to combat the adverse effects of physical inactivity. Even a 
fraction of the adaptations might be of help in improving health, such as improving 
metabolism in diabetic patients or maintaining muscle mass in cancer patients. In this context, 
understanding the mechanisms governing these adaptations is crucial to develop therapeutic 
strategies.  
3.2 SKELETAL MUSCLE ADAPTATIONS TO EXERCISE 
Skeletal muscle constitutes 40% of human body mass and contributes to the adaptation to 
changes in energy demand as well as whole-body energy homeostasis. Muscle contractions 
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contribute largely to our posture, breathing, and movement. As the primary tissue that enables 
physical activity, skeletal muscle often receives considerable attention in the context of 
exercise physiology. 
Muscle response to exercise involves numerous changes in cellular processes including 
contractility to generate force and movement, mitochondrial content and function to meet 
with energy demands, tissue remodeling to repair muscle fiber damage, and transcriptional 
regulation to orchestrate it all (118–120). These processes are a culmination of a progressive 
change in mRNA and protein content which would then translate to optimal performance to 
maintain metabolic homeostasis in the face of an acute energetic challenge(121). Although 
this wave of changes stimulates a response, this transient response starts to fade away within 
hours and diminishes in a matter of days. Only when repeated, these acute pulses accumulate 
to long-term changes that facilitate maximal contractile function, substrate utilization and 
eventually improved muscle metabolism and resistance to fatigue (122). Consequently, while 
acute exercise triggers temporary changes, the majority of chronic adaptations to exercise 
results from the cumulative effect of regular exercise. These adaptations vary depending on 
a range of factors, including the exercise type, duration and intensity as well as the individual 
resting state, age, and the genetic background (123–126). 
Different exercise types elicit different physiological changes leading to a training-specific 
outcome. Simplistically, these are improved aerobic capacity for endurance exercise and 
increased muscle mass and strength for resistance exercise. Recent reviews cover the subject 
of exercise-induced hypertrophy and its regulation in great detail (127, 128). In the context 
of this thesis, the focus will be on the adaptations to endurance exercise.  
3.2.1 Energy metabolism 
Early adaptations to an acute bout of exercise include transcriptional changes in genes that 
mediate muscle function (129, 130). Moreover, around 1000 phosphorylation sites on over 
550 proteins are reported to change following acute exercise demonstrating the vast network 
of pathways modified by exercise (131, 132). Many of these acute changes are related to 
energy metabolism.  
Muscle contraction requires energy to fuel cellular mechanisms that contribute to force 
generation. These mechanisms depend on ATP and include maintaining an excitable 
sarcolemma, Ca2+ signaling through sarcoplasmic reticulum and the actin-myosin machinery 
(120). Metabolic factors such as enzymatic capacity, fuel and oxygen delivery influence the 
capacity to meet with the energy demands during exercise (116, 133). In addition, the nature 
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of the exercise, as in exercise intensity, duration, and mode, have a substantial effect on fuel 
utilization and source (126, 134). While the intensity of the exercise determines the fuel 
source and stimulates mobilization of extra fuel from energy stores if necessary, the energy 
expenditure and the ATP demand are tied up to the required power (122).  For low-intensity 
exercise, the main energy source is glucose from circulation or derived from liver glycogen 
and free fatty acids (FFAs) from fat stores. When the sub-maximal exercise is kept at same 
intensity but prolonged, the contribution from lipid oxidation increases with the duration of 
exercise (122, 135, 136). During prolonged low to moderate-intensity exercise, the majority 
of skeletal muscle fibers engaged are of a type characterized by slow contraction and high 
oxidative capacity. Moderate to high-intensity exercise, on the other hand, shifts away from 
lipid oxidation and is more reliant on glucose derived from muscle glycogen (134). For 
example, during a short maximal capacity exercise, such as a sprint, due to the magnitude of 
energy required the regular ATP turnover raises almost 100-fold (137, 138). To exert 
maximal effort, more fast-fibers are recruited which primarily rely on glucose as a fuel. 
Therefore, through oxidative phosphorylation of intramuscular fuel storage, mainly glycogen 
and creatine-phosphate breakdown, the pathways for ATP synthesis get ramped up (139, 
140). After the glycogen stores depleted, additional glucose from the liver glycogen stores 
and more fatty acids from adipose tissue are mobilized to be oxidized (122).  
Conversely, adaptations to long-term regular exercise training are mainly within the 
oxidative metabolism pathways (141). In response to such training programs, skeletal muscle 
boosts transcriptional and enzymatic machinery to maximize its functional work capacity 
(142). To achieve that, fatty acid oxidation, substrate and oxygen uptake increase to feed into 
the oxidative phosphorylation.  
In that sense, muscle metabolism is coupled to the vascular system to promote delivery and 
uptake of oxygen and fuel. In exercised muscle, the vascular system undergoes remodeling 
including an increase in capillary density (142, 143). Alongside, a higher mitochondrial 
content provides the necessary expansion in the capacity of the muscle to oxidize the 
upcoming substrate and generate the ATP required for force and contraction(144).  
Macromolecule and organelle turnover through proteasome system and autophagy is another 
cellular process that participates in the adaptation to the challenges in cellular energy 
homeostasis including exercise (145, 146). Restriction in energy supply stimulates a 
compensatory protein and mitochondria turnover via autophagy to provide components for 
protein synthesis and to maintain homeostasis (146, 147). In an early study, Salminen and 
Vihko demonstrated that prolonged aerobic exercise increases autophagic flux to recycle 
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cellular components for regenerating muscle fibers (148). Particularly, they spotted damaged 
mitochondria in autophagosomes suggesting that in addition to its role in keeping basal 
homeostasis, autophagy serves to mitigate exercise induced disruptions including oxidative 
damage due to dysfunctional mitochondria. Subsequent studies confirmed the essential role 
of autophagy in exercise adaptation both in rodents (149–152) and humans (153–156). 
Blocking formation of autophagosomes diminishes training-induced increase in 
mitochondrial proteins, capillarization and improvement in aerobic capacity and results in 
altered glucose metabolism (150, 152). 
3.2.2 Neuromuscular function 
For skeletal muscle function, muscle fibers rely on the input from axonal branches of motor 
neurons (MNs) in the spinal cord. Another way exercise promotes an increase in functional 
capacity is through improving this communication at the synapse site called neuromuscular 
junction (NMJ) (157). This coupling plays an essential role in almost every voluntary 
movement throughout life.  
Proper NMJ development and function is critical for the skeletal muscle function. With aging 
or neuromuscular diseases, a progressive decline occurs in functional NMJs which is 
associated with loss of motor coordination, muscle weakness and atrophy (158, 159). NMJ 
dysfunction has been implicated as early-onset symptom and progression of sarcopenia and 
also observed in early stages of neuromuscular diseases and ALS (159–162). Lifelong 
activity has been reported to halt the progressive decline by supporting the maintenance of 
functional NMJs, with elite runners keeping their functional motor units into old age (163). 
Additionally, there is evidence showing that an exercise intervention also halts the age-
related decline in NMJ function and morphology (164–166). 
Physiologically and morphologically, NMJs are highly receptive and adaptive to exercise-
induced changes which can occur at both the nerve (presynaptic) and the muscle 
(postsynaptic) compartment. In an early seminal work which analyzed NMJ 
electrophysiological properties of rat skeletal muscle, it became evident that endurance 
exercise induces an increase in stimulus-induced neurotransmitter (mainly Acetylcholine, 
ACh) release and raises resistance to fatigue during sustained stimuli (167). These 
adaptations serve to ensure effective communication from neuron to muscle during prolonged 
neuromuscular activity. Since effective NMJ function is a prerequisite for whole muscle 




Morphologically, exercise leads to increased presynaptic nerve terminal branching both in 
number and total length despite a maintained average branch length (162, 166, 168). In 
addition, nerve terminals contain more ACh vesicles in agreement with the aforementioned 
increased neurotransmitter release.   
Post-synaptic changes 
As the nerve terminal is remodeled, postsynaptic endplate also undergoes an architectural 
change upon exercise. Together with a greater number of ACh receptors (AchR), the total 
area occupied by ACh receptors have been reported to increase (166, 169, 170). Remarkably, 
the release sites at the presynaptic terminals and receptor area on the postsynaptic membranes 
display matching exercise-induced changes. This demonstrates the tight coupling between 
the motor neuron and the muscle fiber to ensure efficient neurotransmission, even when NMJ 
is under significant reconfiguration. In fact, seminal work from the early 90s revealed that 
the training induced changes in the presynaptic terminals exhibit specificity based on the 
properties of the muscle fibers they innervate(171).  
Muscle fiber – motor neuron coupling 
According to their physiological properties motor units are classified into three groups with 
speed of contraction as the main determinant: slow twitch, resistant to fatigue (S), fast-
resistant (FR) and fast-fatigable (FF) (172, 173). In a similar manner to muscle fiber types, 
the functional diversity of motor units enables specification of the muscle fiber recruitment 
order and sustains prolonged activity. Metabolic and firing properties of the motor neuron 
and its motor units are coupled and it has been demonstrated that muscle fibers can adapt 
their contractility to the changes in synaptic input. For example, when fast muscle fibers are 
innervated by a slow motor neuron, they transform to acquire slow twitch fiber properties, 
and vice versa (173). While exercise-induced fiber type changes have been reported before, 
the jury is still out to determine whether exercise can stimulate such a shift. Similarly, our 
understanding of exercise-induced motor neuron plasticity is still limited. Only in recent 
years there has been a stride to reveal molecular signatures of MN identity (174–178) and 
examine the retrograde influence of muscle fiber adaptations on motor neurons and NMJ 
function (178). This topic still remains ripe with opportunity for additional research 
especially because we have just started to understand the detailed effects of exercise training 
on the elegant neuromuscular system and the plasticity of the NMJ.  
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3.2.3 Regulatory mechanisms of skeletal muscle adaptations 
Many of the skeletal muscle adaptations are mediated by the coordinated action of a number 
of signaling and transcriptional regulatory mechanisms for exercise-induced gene expression 
and protein synthesis (120, 122). include Ca2+/Calmodulin-dependent protein kinase 
(CaMK), mitogen-activated protein kinases (ERK1/2 and p38 MAPK) and AMP-activated 
protein kinase (AMPK). Subsequent cascades of reactions result in activation of multiple 
transcription factors and their coregulators (activators and repressors).  
From a molecular perspective, the peroxisome proliferator-activated receptor-g coactivator-
1a (PGC-1a) is a central regulator of several mechanisms that couple cellular energy demand 
and supply(179). Almost all members of PGC-1 family of coactivators have an effect on 
cellular energetics. In addition, depending on the tissue, PGC-1 coactivators can interact with 
a variety of transcription factors to mediate tissue-specific transcriptional programs.  
Following its identification as a transcriptional regulator of genes involved in cold-induced 
thermogenesis in brown adipose tissue (180, 181), an extensive body of work established 
PGC-1α1 as an important regulator of skeletal muscle adaptation to exercise (179, 182–184). 
Skeletal muscle PGC-1α1 expression levels, both mRNA and protein, rapidly increase in 
response to acute exercise (184, 185), with the highest abundance observed in the first couple 
of hours after the exercise (121).   
PGC-1α1 coactivates transcription of hundreds of genes encoding for proteins involved in 
mitochondrial biology through the nuclear respiratory factor and estrogen-receptor-related 
receptor-α (ERRα) while simultaneously promoting mitochondrial-DNA replication and 
transcription (181, 186, 187). Along with promoting consumption of fuel and oxygen in 
mitochondria, PGC-1α1 also facilitates an enhanced fuel and oxygen uptake by inducing 
angiogenesis through increased VEGF expression independent of its traditional regulator 
hypoxia-inducible factor 1 (HIF-1). The PGC-1α1-induced angiogenic gene program is not 
necessary for basal tissue vascularization but it is required for exercise-induced angiogenesis  
(188, 189). Furthermore, overexpression of PGC-1α1 in skeletal muscle increases glucose 
uptake through upregulation of the insulin-sensitive glucose transporter 4 (GLUT4) (190). 
Finally, PGC-1α1 elevates basal autophagic flux and also increases mitochondrial turnover 
in trained muscle (191).  
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Known as the master regulator of mitochondrial biogenesis, high levels of PGC-1α1 bring 
skeletal muscle many advantages including enhanced fuel uptake, oxidative capacity and 
neuromuscular function (179) (Figure 4). Indeed, transgenic animals overexpressing PGC-
1a1 specifically in skeletal muscle (MCK-PGC-1α1) are protected from muscle atrophy, age-
related sarcopenia and insulin resistance (182). Remarkably, the same animals also display 
an extraordinary endurance capacity without training and are resistant to contraction-induced 
fatigue. 
Figure 4: PGC-1 mediated exercise adaptations in skeletal muscle (Correia et al 2015, reprinted with 
permission)  
Interestingly, it has been shown that diabetic mice(192) and humans (193) suggest a loss of 
PGC-1α1 function in skeletal muscle, which could contribute to the mitochondrial 
dysfunction and impaired glucose metabolism observed in these diseases. Considering that 
nearly 85% of the insulin-stimulated glucose uptake happens in skeletal muscle, factors 
regulating this process influence whole-body glucose metabolism. Moreover, mice lacking 
PGC-1α in whole body have defective autophagy machinery and impaired mitophagy 
suggesting that PGC-1α1 is necessary for exercise-induced autophagy (194). 
Since any skeletal muscle function is dependent on neuromuscular function, it is also not 
surprising that PGC-1α1 is driving some of the exercise induced changes in NMJ structure 
and function (178, 195–197). Strong evidence highlights that PGC-1α1 coactivates the 
transcription of a variety of genes that are involved in improving post-synaptic NMJ 
morphology and function (195, 196). Its absence retards AchR clustering and reduced levels 
of critical genes for NMJ function such as AchRs, muscle-specific kinase and utrophin, 
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suggesting that PGC-1α1 plays an essential role in NMJ maturation and maintenance (195). 
Its utility has been put to use in a mouse model of muscle dystrophy where skeletal muscle 
PGC-1α1  expression ameliorated muscle function and in a genetic model of ALS carrying 
SOD1G37R mutation where muscle PGC-1α1 increased AchR clustering and helped retain 
muscle mass and function (195, 198). 
The effects of PGC-1a on NMJ are not limited to the postsynaptic level and expand into the 
presynaptic compartment as well (178, 196, 197). Transgenic mice overexpressing PGC-1a 
in the skeletal muscle exhibit longer branches and more synaptic vesicles at the nerve 
terminals. In addition, it appears that these animals have a high frequency of slow motor units 
where fast fibers were innervated by slow motor neurons (196). This confirmed the initial 
findings reported by Chakkalakal et al. suggesting that muscle PGC-1α1 can have an 
influence on the coupling between motor neuron and muscle fiber identities(178). Taking the 
oxidative and fatigue resistant phenotype induced by muscle overexpression of PGC-1α1 into 
consideration, the shift towards slower identity is plausible and it fits the physiological 
output. A similar shift happens when PGC-1α1 is delivered postnatally, after synapse 
elimination at the NMJ is completed. It is important to note that muscle-driven plasticity of 
motor neuron identity has long been sidelined and understudied. The specific signals that 
might act retrogradely to induce this effect remain to be determined and offer new 
possibilities for diseases that involve neuromuscular dysfunction. In this regard, using a 
microfluidics system to model muscle-MN communication and NMJ formation, our group 
recently identified a neurotrophic factor called Neurturin (NRTN) that acts downstream of 
PGC-1a1 and mediates its effects on pre-synaptic remodeling by promoting motor neuron 
recruitment as well as NMJ formation (197).  
3.3 WHOLE-BODY ADAPTATIONS TO EXERCISE 
Although the muscle plays a big part, both acute and regular voluntary exercise orchestrates 
numerous adjustments well beyond the skeletal muscle (116). As the motor cortex drives the 
locomotion through spinal cord and muscles, the brain also signals to other systems to ensure 
metabolic demands are met and the whole-body homeostasis is maintained.  
Accumulating evidence shows that exercise improves brain function in multiple ways both 
in rodents and humans (199–201). Improvements in cognition, motor coordination and 
balance, memory and learning are to name a few. Accordingly, the pathology of a variety of 
neurological diseases such as stroke, traumatic brain injury, anxiety and depression are 
alleviated by physical exercise. Some of the beneficial effects of exercise have been attributed 
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to direct changes in intramuscular mechanisms regulating potentially detrimental 
mechanisms. For example, exercise offers protection from stress-induced depression through 
PGC-1α1 mediated kynurenine detoxification (202, 203). 
Cardiovascular and respiratory systems are critical for the whole-body adaptations to 
exercise. Increased cardiac function together with improved vascular system contributes to 
an enhanced aerobic capacity which is protective against cardiovascular diseases (204). The 
respiratory system increases ventilation proportional to the exercise intensity and facilitates 
sufficient oxygenation (116). In addition, sympathetic and autonomous systems monitor and 
adjust critical parameters such as heart rate, blood pressure among others. 
Exercise-driven effects in energy metabolism observed in skeletal muscle are also reflected 
to adipose tissue. Among these are elevated mitochondria content, increased free fatty acid 
mobilization, beta-oxidation and lipolysis (205, 206). In parallel, liver metabolism drastically 
changes in response to energetic demands of exercise(207). As a nutrient sensor, the liver is 
in a critical position to maintain whole body energy homeostasis during fasting or high energy 
demand situations where glucose is in short supply. As skeletal muscle glycogen stores get 
depleted, glucose release to bloodstream from liver increases, first through hepatic glycogen 
breakdown (glycogenolysis) and then from non-carbohydrate substrates (gluconeogenesis). 
In addition, secreted proteins from the liver, such as the insulin-like growth factor 1 (IGF1), 
are involved in glucose metabolism.  
Under low glucose conditions like prolonged intense exercise, the liver produces ketone 
bodies as an alternative energy source for oxidative phosphorylation (208). Of these, b-
hydroxybutyrate which can cross the BBB, has been reported to increase in circulation after 
voluntary wheel running in mice and promote exercise-induced plasticity in the brain through 
neurotrophic factors (209).  
Exercise also effects immunity although in a complex and context dependent manner (210–
212). Regular exercise is known to reduce systemic inflammation levels (213). Conversely, 
some studies claim prolonged intense exercise triggers systemic inflammation and increases 
infection risk (213–215). Furthermore, muscle repair and regeneration requires a precisely 
orchestrated immune cell activation (211, 212). The detailed mechanisms of the exercise-
immune system interplay still remain enigmatic and may involve fine tuning of inflammatory 
cues from multiple sources. Interleukin-13 (IL-13), for example, is released by resident 
immune cells in the exercised muscles and enhance endurance by increasing metabolic 
flexibility in mice (216).  
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4 INTER-ORGAN COMMUNICATION 
At any given time, an intricate network of communication coordinates a multitude of basal 
mechanisms to keep homeostasis which results from collaborative effort by multiple systems 
and organs. During a challenge induced by an external stress, such as exercise, each member 
of this network triggers an adaptive response and activates another channel for crosstalk so 
the system as whole can ensure proper function.      
In this realm, there has been much effort to expand our knowledge about mechanisms 
involved in the inter-organ communication, both in health and disease. Systemic factors 
involved in this process can originate from multiple tissues and cell types, go through a 
complex journey spanning various organs and stimulate different downstream signals. So far, 
we only scratched the surface of this journey, albeit only for specific factors and conditions. 
Inquiries into the circulating factors employed a range of strategies from the century-old 
parabiosis (38, 217, 218) to plasma transfer (219–221), advanced large-scale proteomics 
(222–224) and bioinformatic tools (225). 
In the context of exercise and skeletal muscle, although the clinical benefits of exercise have 
been known for a long time, the bulk of what we know about the systemic mediators of these 
effects are relatively recent discoveries. Future investigations into muscle-derived factors that 
enact exercise-related changes in distant parts of the body could provide useful tools to our 
arsenal in fighting with effects of inactivity, aging and associated disorders.  
4.1 MUSCLE AS A SECRETORY ORGAN 
More than half a century ago, Goldstein hypothesized that skeletal muscle released a humoral 
factor in response to the elevated energy demands during physical activity (226). The early 
view was that the contracting skeletal muscle induces a physiological and metabolic response 
in other organs and this may be independent of the nerve input. This hypothesis was 
strengthened with the finding that electrically-stimulated muscles lacking both efferent and 
afferent nerve impulses due to spinal cord injury induce nearly same physiological changes 
as the uninjured muscles of healthy patients (227–229). So, the quest to decipher the language 
of the skeletal muscle began.  
It was during the search for a link between changes in the immune system and muscle 
contractions when Pedersen and colleagues turned to cytokines as potential messengers. In a 
study with marathon runners, they observed a robust increase in Interleukin-6 (IL-6) levels 
in the post exercise plasma and at first considered it as a result of immune response to 
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prolonged exercise (230, 231). Instead, Steensberg et al. revealed that the skeletal muscle-
derived IL-6 accounts for the elevated levels in circulation (232). Further studies confirmed 
the metabolic effects of muscle-derived IL-6, mainly as an energy sensor mediating glucose 
turnover during exercise (232–235). Altogether, these studies and others accumulated into 
the hypothesis that muscle-derived cytokines may be involved in exercise-induced changes 
and long-term metabolic adaptations. 
Identification of muscle as a secretory organ opened up new avenues of research. In a way, 
it paralleled the concept of adipose tissue as an endocrine organ, which was initially regarded 
as fat storage and later on revealed as a major secretory organ thanks to the work of the 
Spiegelman group (236) towards the end of the 1980s, the Friedman group in the 1990s (237) 
and the following discoveries of adipokines ( reviewed in 182,213).  
Myokines  
Echoing the term adipokine, in 2008 Pedersen and Febbraio coined a term for the “muscle 
cytokines” and called for “cytokines and other peptides that are produced, expressed, and 
released by muscle fibers and exert either autocrine, paracrine, or endocrine effects” to be 
classified as myokines (239).  
By now, the research into myokines revealed that several hundred peptides are secreted from 
skeletal muscle (240) and novel myokines continue to expand our understanding of how 
skeletal muscle communicates with the rest of the body.  
4.2 MYOKINES WITH AUTOCRINE AND PARACRINE EFFECTS 
The adaptive response to exercise likely reflects the combined action of myokines and other 
factors to induce profound changes in skeletal muscle transcriptional machinery as discussed 
above and overall metabolism. Different myokines elicit different and sometimes redundant 
effects on muscle physiology, which indicates that despite having overlapping functions, the 
outcome may be regulated by their abundance, receptor availability and other spatially 
delimited cues.  
4.2.1 On muscle metabolism 
The first muscle-derived factor to be named as myokine, IL-6, was discovered due to its 
effect on muscle glucose metabolism in an autocrine fashion. Known primarily as a pro-
inflammatory cytokine, IL-6 has been implicated in insulin resistance in obesity and type 2 
diabetes (239, 241). At first, IL-6 involvement in the metabolic response to exercise appear 
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counterintuitive due to its pro-inflammatory characteristics and the anti-inflammatory nature 
of exercise. However, there is evidence that exercise-induced IL-6 release from the skeletal 
muscle is highly proportional to the duration and intensity of the exercise and has beneficial 
effects on muscle metabolism (212, 242). Systemic administration of IL-6 to mimic the 
exercise effect in humans sensitizes skeletal muscle to insulin and promotes GLUT4 
translocation to the plasma membrane (233). Moreover, in vitro and in vivo evidence suggest 
that this action is mediated by AMPK. Contrary to what might have been expected, 
preclinical studies with IL-6-deficient mice showed no difference in glucose uptake or 
AMPK activity after treadmill running or at resting state (243, 244) or restricted to a specific 
muscle type (245). In addition, energy metabolism appeared to be unaltered in mice with 
embryonic IL-6 deletion in muscle (246). Although these data raise questions on the role of 
IL-6 in skeletal muscle glucose uptake, additional investigations using inducible tissue-
specific conditional knockout models should allow a more careful dissection of pleitropic 
nature of IL-6 actions.  
Muscle contraction and exercise also promote expression of brain-derived neurotrophic 
factor (BDNF). Although BDNF is mainly known for its actions on neurons (247, 248), for 
muscle fibers it can also act as a metabolic regulator in response to exercise(249, 250). 
Human muscles ramp up BDNF expression following exercise and in turn BDNF enhances 
lipid oxidation in an AMPK-dependent manner, thus BDNF contributes to fuel selection and 
energy expenditure in skeletal muscle(251). In a similar way but through different 
mechanism, another exercise-induced myokine called Musclin influences energy expenditure 
by promoting mitochondrial biogenesis through PGC-1α1 (252, 253) .  
4.2.2 On muscle growth 
Besides metabolic improvement, another exercise-induced change that can be locally 
influenced by myokines is muscle growth. Myostatin (MSTN), one of the oldest myokines 
that fulfils the criteria outlined by Pedersen & Febbraio (239), is known to negatively regulate 
muscle growth (254, 255). Famously, genetic ablation of MSTN results in a massive muscle 
hypertrophy phenotype in mice (255), dogs (256) cattle (254, 257) and humans (258). With 
such a distinctive knockout phenotype, the regulation and function of MSTN received a lot 
of attention with hopes of utilizing this information to boost muscle mass in a variety of 
species, including humans. Therapeutically, control of muscle mass by MSTN have been 
explored in a number of muscle-wasting conditions (259). One of these is complete spinal 
cord injury (SCI), which in rodent models led to an increased sensitivity to MSTN (260). 
Blocking MSTN throughout 8 weeks-post-SCI recovered some of the body mass but mostly 
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in the upper limbs and not in the paralysed muscles indicating that MSTN inhibition alone is 
not sufficient to prevent muscle loss after denervation-induced muscle wasting. MSTN has 
also been associated with the pathogenesis of muscle wasting in cancer cachexia and 
sarcopenia. (261–264). The effects and the clinical premise of MSTN for these muscle 
wasting conditions still need to be explored taking the progressive and complex nature of 
muscle loss into account. Similar to MSTN, myotube-produced IL-6 is also reported to 
regulate satellite cell-mediated myogenesis where the genetic deletion of IL-6 led to muscle 
hypertrophy (265). Yet the complexity of IL-6 biology also calls for a matching multifaceted 
approach to dissect this connection to muscle size. Another recently identified myokine, 
apelin, is proposed as an autocrine agent that induces muscle hypertrophy (266) and 
interestingly there is some data showing an age-related progressive decline in skeletal muscle 
apelin expression suggesting a potential contribution to age-related sarcopenia(267).  
4.2.3 On neuromuscular function 
Myokines can mediate muscle function through remodelling of NMJs. As a factor closely 
associated with motor neuron survival and function, it comes as no surprise that BNDF has 
effects on NMJ morphology and function. In a recent study, Delezie et al. demonstrated that 
skeletal muscle-specific BDNF knockout reduces endplate volume, promotes glycolytic 
muscle fiber phenotype and enhances endurance performance (250). Increasing evidence 
places BDNF as an emerging myokine with effects on skeletal muscle metabolism and 
function.   
Finally, covering all the myokines with autocrine or paracrine effects which are reviewed 
elsewhere would go beyond the scope of this thesis (268, 269). 
4.3 MYOKINES WITH ENDOCRINE EFFECTS  
4.3.1 On neurological functions 
Over the course of a millenia, philosophers argued a version of the latin phrase “Mens sana 
in corpore sano” meaning a healthy mind in a healthy body. Evolutionary, epidemiological 
and clinical evidence have demonstrated the neurobiological benefits of exercise suggesting 
a link between skeletal muscle and central nervous system (CNS). Although the existence of 
such a link has been speculated for a long time, the underlying mechanisms and systemic 
mediators of this connection have remained largely unexplored until recently. Even though 
many myokines have autocrine or paracrine functions as discussed above, some are released 
into the bloodstream and affect other organs. The ever-expanding research into muscle 
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secretome and myokines may, at least in part, provide insight into the long-suspected 
connection between skeletal muscle and CNS.     
CNS adaptations to exercise are broad but perhaps the most prominent are the changes in 
hippocampus and the memory driven by BDNF. In addition to its role in the benefits of 
physical activity in the brain, multiple reports suggest that BDNF may also take part in 
metabolic and behavioral responses to exercise, including glucose metabolism (10, 270). 
Indeed, evidence from human studies show that exercise-induced BDNF expression is not 
confined to brain, it is also induced in the skeletal muscle (271). However, the findings on 
whether the muscle-derived BDNF is released to circulation after exercise have been 
inconclusive. Some studies report an increase and others no change or a decrease in the 
peripheral levels of BDNF (199, 271). Several factors could contribute to this inconsistency 
including exercise intensity and duration, type of exercise, and measurement method to name 
a few. Of note, these studies often do not aim to distinguish the source of BDNF and just 
determine the serum or plasma level upon exercise.  
While the debate whether muscle-derived BDNF is released into circulation remains 
inconclusive, FNDC5/Irisin, a myokine primarily known for its role in exercise-induced 
browning of adipose tissue has also been shown to induce BDNF expression in the 
hippocampus after endurance exercise (272). Blocking FNDC5 specifically in the brain 
results in impaired hippocampal plasticity and memory while boosting the FNDC5/Irisin 
levels rescues this phenotype (273). Furthermore, these effects seem to be translated to 
peripheral administration of FNDC5/Irisin, which offers protection against Aβ-induced 
memory impairment. Myokines mediating beneficial effects of exercise are often altered in 
age-related neurodegenerative diseases where cognitive impairment is accompanied by 
aggravated muscle loss and physical inactivity. In line with this, Lourenco et al observed that 
levels of FNDC5/Irisin were markedly reduced in the cerebrospinal fluid and the 
hippocampus of AD patients (273). Although cleavage and secretion of FNDC5/Irisin is still 
subject of a debate, systemic elimination from circulation with a neutralizing antibody seem 
to abolish the effects of exercise on cognitive function in an AD mouse model (273). 
Some recent studies pinned a role to another myokine cathepsin B (CSTB) in exercise-
induced brain plasticity. Treadmill running elevates CTSB levels in gastrocnemius muscle 
and plasma and CTSB levels in human plasma positively correlates with the fitness level as 
well as spatial memory. In addition, genetic ablation of CTSB hampers the memory 
improvement and adult neurogenesis associated with voluntary running in mice (274). 
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However, CTSB function in the CNS has been a controversial topic due to its pathogenic 
effect promoting cell death following several brain injury models (275, 276). 
4.3.2 On energy metabolism 
Given that adipose tissue is the largest site of energy storage in the body, muscle and adipose 
tissue are functionally connected coordinators of energy homeostasis. Increased energy 
demand during exercise is met by fatty acid mobilization from the adipose tissue to skeletal 
muscle where an internal machinery to enhance fatty acid oxidation is also triggered by 
exercise. Myokines are involved in this axis have effects on lipolysis and adipose tissue 
metabolism. Exercise induced IL-6 secretion serves to feed this energy loop where skeletal 
muscle release of IL-6 stimulates lipolysis and FA mobilization to provide necessary fuel for 
the sustained physical activity (277).  Besides being an energy storage, adipose tissue, 
depending on its location and type, can also serve as a source of heat to protect against cold 
exposure(278) This thermogenic regulation is another way myokines affect adipose tissue 
metabolism and it is achieved by promoting a brown adipose tissue phenotype with increased 
energy expenditure.   
FNDC5/Irisin is one of these myokines promoting a brown fat phenotype in response to 
exercise (279). In mice, acute treatment with recombinant FNDC5/Irisin is sufficient to 
induce browning and insulin sensitivity while in humans there is still ongoing debate around 
this topic. Similarly, another myokine called meteorin-like (Metrnl) has been identified as 
downstream effector of PGC-1a isoform 4 with effects on thermogenesis and browning and 












Overarching aim of this thesis is to investigate mechanisms involved in the systemic effects 
of physical inactivity and provide new perspectives for future therapeutic interventions.  
Specific aims: 
Paper I: To understand the mechanisms that regulate Presenilin-1 function on Alzheirmer’s 
disease pathogenesis  
Paper II: To investigate the molecular signatures of inherent and response components of 
aerobic exercise capacity in the skeletal muscle and utilize them to predict muscle-derived 
factors that can have systemic effects  
Paper III: To delineate the role of the neurotrophic factor Neurturin in the skeletal muscle 




6 RESULTS AND DISCUSSION 
6.1 PAPER I: ANTI-AMYLOIDOGENIC FUNCTION OF PRESENILIN 1 
One of the hallmarks of AD is Aβ-associated toxicity, including the senile plaques that are 
often used as a post-mortem diagnostic marker. The γ-secretase complex is an essential 
enzyme for APP processing, and its catalytic subunit Presenilin 1 (PS1) is mainly responsible 
for Aβ generation in neurons. Despite its pivotal role, the precise mechanisms that govern 
PS1 function have remained enigmatic. In Paper I, we investigated potential mechanisms 
that can regulate PS1 function and uncovered a unique role for PS1 in Aβ metabolism (Figure 
5). We showed that PS1 can reduce Aβ production by directing β-CTF for autophagic 
clearance and provided mechanistic evidence for PS1-phosphorylation at serine 367 (S367) 
as a regulator of this activity.     
Studies of PS1 phosphorylation indicate that it does not affect γ-secretase activity, while 
some specific residues are suggested to potentially influence its stability or conformation 
(281). In addition, cryo-electron microscopy revealed that human γ-secretase displays a 
closed conformational structure associated with its pathogenic activity (282). Detailed 
analysis of PS1 phosphorylation pattern pointed at potential sites that seem critical for this 
closed pathogenic conformation (283). S367 was among these sites and it seemed to have a 
critical role in mediating PS1 activity. Our investigation identified its role as a signal to 
promote degradation of β-CTF before it is further cleaved to produce Aβ.  
To study protein phosphorylation, performing amino acid substitutions to alter the chemical 
characteristics is a commonly used approach. For example, substitution of the serine (Ser) 
residue by alanine (Ala) serves to prevent phosphorylation at that particular residue as Ala is 
not chemically receptive to phosphate groups. Using this approach, we developed an in vivo 
substitution model where S367 is replaced by Ala in J20, a murine model of AD (here in J20-
S367A animals are referred as S367A). In agreement with the findings of Maesako et al, this 
substitution did not interfere with γ-secretase activity demonstrating phosphorylation of S367 
does not influence assembly or function of γ-secretase (283). Interestingly, both soluble and 
insoluble Aβ levels increased in the brains of S367A animals and they displayed a heavier 
plaque burden in the absence of S367 phosphorylation.   
For a positive control, we wanted to model S367 phosphorylation in the same way as S367A 
and replaced the S367 with aspartic acid residue which chemically resembles the 
phosphorylated Serine (S367D). However, these animals did not show the autophagy-driven 
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protective effect with similar levels of Aβ and plaque deposition as S367A. There can be 
multiple reasons for this, starting with the challenge of achieving a true phosphomimetic 
substitution of Serine with Aspartic acid. Others have reported similar failures to mimic the 
actual phosphorylation effect (284–287). Structure and charge of the phosphate group could 
be necessary for this particular activity, or the structural properties of replaced residue might 
influence the outcome.  
We also set out to identify the kinase responsible for phosphorylating this residue. Using 
motif-based prediction tools, we identified the casein kinase 1 (CK1) family as a candidate. 
This was in line with previous data pointing at the potential involvement of CK1 in γ-
secretase regulation (288). A systematic in vitro knockdown of known isoforms and 
treatment with isoform specific inhibitors revealed CK1γ isoform phosphorylates PS1 at 
S367. Based on our findings, CK1γ activators can be explored as potential therapeutic agents 
for AD.  
Autophagy and APP processing has been linked in some studies (289–291). Based on our 
results, both in vitro and in vivo evidence points to impaired autophagic flux in the absence 
of PS1 S367 phosphorylation. In a parallel study, our group further detailed this mechanism 
showing that PS1 phosphorylation at S367 facilitates autophagosome-lysosome fusion (292).  
 
Figure 5: Working model for the dual role of PS1 in Aβ metabolism (293). 
Taken together, these results suggest that PS1 phosphorylation at S367 is crucial for βCTF 
degradation through autophagy. The implications of this study are broad as they open a new 
avenue in PS1 biology and Aβ metabolism. If broad or neuron-specific autophagic 
impairment drives the pathology of AD, advancing our understanding of autophagy-
promoting mechanisms such as exercise and their specific mediators could potentially be 
exploited as preventive measures for neurodegeneration.   
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6.2 PAPER II: DISSECTING INTRINSIC AND ADAPTIVE COMPONENTS OF 
EXERCISE CAPACITY 
There are numerous benefits to increasing exercise capacity, including reduced mortality and 
morbidity rates. Conversely, low exercise capacity is linked to a higher risk of developing 
complex diseases. In this study, we revealed muscle transcriptional signatures of intrinsic 
aerobic capacity and response to aerobic training in rats and humans.   
Exercise capacity is a complex trait and is linked to chronic metabolic disorders. We took 
advantage of a novel approach to study the intrinsic and acquired exercise capacity in skeletal 
muscle. In the early 2000s, Koch and Britton developed low and high aerobic capacity rat 
models using a two-way selective breeding strategy based on untrained endurance running 
performance (113, 115). Similar to humans, exercise capacity also involves an inheritable 
component for these rats, therefore selective breeding led to the divergence of low and high 
capacity runner rats (LCR and HCR). A similar breeding strategy for response to training led 
to the low and high responder rat lines (LRT and HRT), which have the same baseline 
capacity but divergent responses to aerobic exercise training.  
Using these models, our muscle transcriptome analysis identified potential molecular 
pathways and genes that might influence aerobic exercise capacity and response to aerobic 
exercise. Since there is no “wild type” control for these models, comparisons are done 
between the extremes, creating a duality in the results. For instance, if a differentially 
regulated gene is induced in HCR, it is reduced in LCR. The muscle transcriptome of HCRs 
was enriched for genes related to angiogenesis and oxygenation, well-known muscle 
adaptations to exercise (294–298). Conversely, the LCR transcriptome profile was associated 
with biological functions concerning inflammation and cardiovascular disease. This is in line 
with the reports documenting the poor health condition of LCR rats and their risk of 
developing complex diseases (299–302).  Altogether, these findings suggested that the 
transcriptional profiles can be useful for investigating mediators of exercise capacity.   
Our analysis for potential upstream regulators pointed at DNA methylases as activated in 
LCRs and reduced in HCRs. An extensive body of knowledge links DNA methylation and 
genetic inheritance and regulation of gene expression. Although the exact mechanisms 
remain elusive, there is some evidence suggesting that exercise induces DNA 
hypomethylation in the human skeletal muscles (303, 304). Considering the inheritability of 
exercise capacity, this could be a potential mechanism to pass it on to the offspring.  
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An obstacle to fully harness the therapeutic potential of exercise programs is the variability 
in individual response to training. Therefore, understanding what factors govern the adaptive 
capacity holds a great value to devise future exercise-based therapies. Skeletal muscle 
transcriptome of HRT-trained (HRTT) and LRT-trained (LRTT) rats did not show obvious 
signatures compared to the HCR-LCR rats. Skeletal muscle has been shown to be a major 
contributor to the HCR phenotype with increased local oxygenation, vascularization and 
enhanced fuel handling (294, 296, 297, 305). Exercise training response, on the other hand, 
might involve other organs and mechanisms. When trained, low responders regulated a 
higher number of genes compared to high responders. This raises the possibility that inherent 
inhibitory systems may be acting to prevent exercise adaptations, for example, inflammatory 
cues (306, 307). 
Secreted factors (secretome) could execute wide-reaching effects and could provide new 
avenues to harness the health benefits of exercise. We employed a bioinformatic pipeline to 
predict muscle secretomes of exercise capacity and response. One striking result is the high 
number of circulatory factors predicted to be enriched in the high capacity muscles. Inherent 
high exercise capacity may rely on high levels of such factors involved in energy metabolism. 
Conversely, responders are predicted to have more factors secreted to the extracellular 
matrix. Interestingly, these were upregulated in low responders. Failure to cope with the 
repeated stress from the exercise training could induce a signal for repair and remodeling in 
LRTT muscles. This is consistent with previous data on exercise-induced pathways in both 
rats and humans (306).   
Lastly, we compared muscle transcriptome signatures of exercise capacity and response 
profiles of rats and humans (123). Correlation of mitochondrial respiration levels with gene 
expression at the untrained state revealed 8 genes shared between rats and humans with high 
aerobic capacity. Interestingly, expression of a known epigenetic modulator, PKD1, 
positively correlated with aerobic capacity in humans. There is active research into epigenetic 
modifications and inheritance of exercise adaptations and diet-induced changes (308). 
Possibly, PKD1-mediated histone modifications might be involved in determining the 
intrinsic exercise capacity. Additional investigation into validating this correlation and 
detailing potential links to exercise responsive genes could further this hypothesis.  
Overall, this study lays the foundation for dissecting the molecular signatures of exercise 
capacity and response in skeletal muscle. Understanding the drivers and mechanisms of these 
components could have a big impact on the ongoing efforts to design personalized exercise 
programs as a prevention and therapeutic intervention strategy.   
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6.3 PAPER III: EXERCISE-INDUCED MYOKINE NEURTURIN PROMOTES 
SLOW MOTOR NEURON IDENTITY, ENHANCES OXIDATIVE 
METABOLISM, ENDURANCE AND MOTOR COORDINATION  
It is widely appreciated that the transcriptional coactivator PGC-1a mediates many of the 
known exercise benefits, including skeletal muscle adaptations. Pharmaceutical targeting of 
skeletal muscle PGC-1a could induce some of the exercise adaptations and expand the 
possible treatment options for many muscular, metabolic, and neurological disorders. 
However, efforts to activate or mimic PGC-1a have been largely unfruitful (309), mainly 
because transcriptional coactivators are quite challenging therapeutic targets and systemic 
activation of PGC-1a could have unwanted effects (310). For this reason, much effort is 
directed at identifying factors acting downstream of PGC-1a which would circumvent these 
hurdles and still deliver some of the PGC-1a mediated effects.   
In this study, we explored one of the myokines known to be induced by PGC-1α1, NRTN, 
and its effects on muscle metabolism and function (Figure 6). Among the known PGC-1a-
induced myokines, which mainly act systemically as endocrine agents, NRTN stands out with 
its autocrine effects on muscle metabolism and retrograde influence on motor neurons at the 
same time. Our results indicate that NRTN holds a therapeutic value both from the metabolic 
and neuromuscular perspectives. To explore the effects of muscle-derived NRTN, we 
generated a transgenic mouse expressing NRTN under the human skeletal muscle actin 
promoter (HSA-NRTN).  
Metabolically, HSA-NRTN animals closely resemble the phenotype of PGC-1α1 muscle 
transgenic animals (MCK-PGC1α1) (182). They exhibit a similar switch in metabolic 
characteristics of muscle fibers, smaller and more oxidative fibers with enhanced 
mitochondrial function and increased vascularization. At the same time, NRTN seems to 
reprogram the muscle transcriptome to optimize energy metabolism, in particular fuel 
handling. Expression of genes involved in fatty acid uptake, intracellular transport and 
oxidation were markedly induced while glycolytic genes were repressed in skeletal muscles 
of HSA-NRTN mice. Although these animals are leaner and have improved glucose 
metabolism, there was no change in energy expenditure or adipose tissue-driven 





Figure 6: Summary of paper III results. Myokine Neurturin enhances calcium handling, 
vascularization and oxidative metabolism in the skeletal muscle. Alongside, Neurturin promotes a 
slow motor neuron identity. Functional outcomes of muscle-derived NRTN are better motor 
coordination, endurance performance and improved metabolism. 
Our data demonstrate a NRTN-driven shift towards slow MN characteristics. HSA-NRTN 
animals display smaller NMJs with less complexity and reduced branching at nerve 
terminals, which morphologically describe slow MNs (311). This is another point where 
HSA-NRTN phenotype does not fully overlap with that of MCK-PGC-1α1 (312, 313). 
Similarly, NRTN did not activate a post-synaptic gene program in the muscle fibers, unlike 
PGC-1α1. Together, our data indicates that NRTN-induced NMJ remodeling results from its 
retrograde signaling to MNs. Indeed, transcriptomic analysis of spinal MNs of HSA-NRTN 
mice showed transcriptional changes with reduced expression of fast MNs markers (Chodl, 
Calca) and a trend towards increased slow MN markers (Sv2a, Esrrb). Although not planned 
as an experimental output, genotype-blind laser capture microdissection of MNs indicated a 
shift towards smaller soma size in these animals which is consistent with slow MN identity. 
Overall, these results demonstrate an extraordinary role for muscle fiber-derived NRTN in 
remodeling NMJ and retrogradely mediating MN identity. 
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Other studies also demonstrated some muscle-secreted neurotrophic factors acting on NMJs 
(178, 250, 314). However, it seems that neurotrophic factors induce different changes on 
NMJ and muscle function even though they all promote neuronal survival and growth. From 
the same family, muscle-derived glial cell line-derived neurotrophic factor (GDNF), induces 
poly-innervated NMJs with larger motor units (314, 315). Even though they share a co-
receptor and act as trophic factors for motor neurons (197), based on our and others data, 
NRTN does not induce the same effect as GDNF (316). Similarly, a recent study showed that 
muscle-derived BDNF promotes a shift towards glycolytic fiber features and a smaller NMJ 
endplate volume, acting exactly opposite to NRTN (250). Consequently, the adaptation to 
exercise probably results from the combinatorial response from different neurotrophic factors 
and the spatiotemporal changes in their abundance could affect the final outcome. This could 
explain the relative low amounts of NRTN in human skeletal muscles as function of 
neurotrophic factors could depend on spatiotemporal cues. 
Functionally, NRTN transgenic animals display impressive motor coordination and 
improved performance on the treadmill. This goes in line with the shift towards slow motor 
units which provide higher fatigue resistance compared to FF units. We demonstrated that 
systemic delivery of NRTN has an influence on skeletal muscle and leads to an improvement 
in motor coordination and glucose metabolism, raising hopes for its potential utilization for 







































7 CONCLUSIONS AND FUTURE PERSPECTIVES 
One of our best weapons against chronic diseases such as neurodegeneration and metabolic 
dysfunction is physical exercise. However, our understanding of these three and their 
underpinning mechanisms is still incomplete and requires more research to facilitate the 
development of novel health-promoting strategies. In that sense, the studies that make up this 
thesis served to extend our understanding of neurodegeneration, explored the mechanisms 
underlying exercise capacity and function and laid out biological function of a potential agent 
that can act on metabolism and neuromuscular function.    
In the AD physiology, autophagy has been documented as a “double-edged sword”.  With 
some studies showing reduced Aβ pathology upon its stimulation and others pointing at 
autophagosomes as an Aβ production compartment (77, 290, 317–319). It would be 
interesting to investigate if any autophagy-modulating small molecules could activate this 
PS1 S367 favored-degradation of Aβ. Also, further research is required to determine whether 
specific variants of the γ-secretase complex and PS1 determine the balance between its 
contrasting actions.  
Alternatively, exercise has been shown to induce autophagy both in the periphery and the 
brains of AD mouse models (150). This is further supported by human studies showing that 
regular exercise improves cognition and ameliorates Aβ pathology in AD patients (320–322). 
Enhanced synaptic plasticity, improved memory and cognition, and resistance to stress have 
been among the known exercise adaptations. Likely, exercise-induced factors may hold some 
answers to reversing hallmarks of aging. Exploring the circulating factors such as myokines 
could carve new paths that can lead to novel targets to circumvent neurodegeneration and 
metabolic dysfunction.  
To achieve this, accurate models to study chronic diseases are essential. However, 
predominant models of complex metabolic diseases may not fully address the underlying 
complexity. Many of the current models might reflect the response to injury or the 
reorganization of biological mechanisms due to the loss of a particular gene. While in reality, 
complex diseases result from the combination of genetic variants and responses to 
environmental factors. Adding to this, chronic diseases emerge not as discrete events, but as 
a group of pathologies, such as metabolic syndrome and neurodegeneration. From this 
perspective, exercise capacity and response models take a more holistic approach to 




One avenue could be developing a better understanding of the systemic factors which 
determine these phenotypes, thus broadening our perspective for new therapeutic targets. 
Recent large-scale multi-omics analyses provide evidence for genomic regulation of plasma 
proteome and suggest that circulating protein levels might be regulated at multiple levels, 
including transcriptional and post-transcriptional changes (222–224). High throughput multi-
omics analyses, including with large cohorts of the exercise capacity and response models 
can provide the perfect landscape and pave the way for further investigations to map out the 
detailed mechanisms and identify new targets, including novel myokines. Unfortunately, 
development of tools for unbiased and high-throughput proteomics still lags behind 
transcriptomic technologies. Yet, emerging technologies for labelling and sequencing 
proteins might soon evolve and list a catalogue of the whole-body secretome (323–325).  
Our understanding of myokines has been expanding. The recent discovery of extracellular 
vesicles (EV) as transport mediums for secreted/circulatory factors has widened the 
perspective to secretome and the scope of potential myokines with endocrine effects (326). 
Further investigations could capture the EV-mediated secreted factors that might contribute 
to the intrinsic exercise capacity and/or response phenotypes.  
As a myokine, NRTN orchestrates a remarkable portion of skeletal muscle adaptations to 
exercise. In addition, NRTN retrogradely influences MNs and promotes a slow MN identity 
which has been associated with resistance to neurodegeneration (172). Clinical trials for 
Parkinson’s Disease aimed at utilizing central and intracranial administration of NRTN as a 
neuroprotective agent failed to report effective outcomes. In the periphery, the effects of 
muscle-derived NRTN seems to originate from its autocrine function. Given its heparan 
sulfate binding properties, possibly NRTN has a limited range of activity once secreted from 
the muscle (327, 328). Potentially, structural modifications in NRTN can relieve its heparan-
sulfate affinity and increase its target range and exposure. Recent strides to unravel the crystal 
structure together with its receptor provide the necessary groundwork for this and future 
research could explore the modified versions of NRTN for treatment of metabolic disorders 
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giving up on your dreams and for being the fun-loving person you are, I wish you lifelong 
happiness together with Agnes! Alberto, I don’t know if it is what you picked up from 
Thessaloniki or not, but it feels like you are from my corner of the world. (: As if we grew 
up in the same town and went to same high school. Thank you for being you, with your heart-
warming smile, hospitality, for the chats and fun over these years, oh and in case no one told 
you yet today, you are such a great scientist! Tatiana, chica, we clicked from the beginning 
and I am so grateful for the open-heart conversations, solidarity. Please stay as wonderful 
and colourful as you are. Mathew, you inspire me with your courage, ambition and wit. 
Thank you for being genuine, sharing your wisdom, for your advocacy work, for “going to a 
conference” with me and the love for spirit animals J   
To the legendary CMB Pub crew; Goncalo, Shahul, Isabelle, Giuseppe, Helena, Thibaud, 
Davide, Pedro, I miss the planning, playlist, shopping, decoration and well, the cleaning fun. 
Until someone does it better, we threw the best pubs on campus. 
Varberg crew, for being the most amazing crew when I first moved to Sweden. Sunjay, 
Aitor, Max, Laetitia, Catrine, Fadwa, David, Naida, Michael, Eleni, Maria. You are the 
only group of people I know who bonded instantaneously. Thanks for such a memorable, fun 
time no matter where we were. I still cherish our sledging with grandma Aitor-tilla, kitchen 
shenanigans with Sunjay, birthday celebrations with delicious cakes from Laetitia, 
Halloween parties where Catrine was dressed as muscle, and Kiruna trip to top it all.  
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To the people of Medicinska Föreningen, to KomU, for being home to Medicor, especially 
Ylva and Alice, for such kindness and organization, Puck, for incredible competence and 
admirable drive. Also to Anton, Pontus, Jessica for always being welcoming and helpful. 
Medicor team, starting with Teresa Fernandez, for being so encouraging, getting me 
involved and for sharing experience and wisdom, Joanne, I could not have made those 
magazines without your incredible work. We were the dream team and I am very proud of 
our work. To the editorial team, Isabel, Katarina, Zach, Veronika, Varsha, it was a 
pleasure to work with you, Jing, Gustav, and everyone that had a contribution in bringing 
this joy into the world. Ben, I never liked writing joint articles, until we did it with you J 
Thank you for your passion for science communication.  
The Doctoral Student Association, I had the opportunity to work with very dedicated people 
to make the world a little better for the next generation PhD candidates. Benedek, you got 
me interested in DSA from the beginning. From that statistics course till today, thank you for 
the friendship, your dedicated work for other students, all the chats and laughter. Iuliia, your 
determination is admirable, keep up the amazing spirit. Nestor, always ready for action and 
full of passion. Your energy is contagious. I miss our discussions in the board meetings, your 
brilliant articles, and all the fun. Keep dancing with life the way you do (: Susanne, your 
sarcasm is like water in the middle of the desert. Thank you for the climbing for dummies 
session. I look forward to bumping into you randomly and ending up sharing life stories. Not 
that you need it but best of luck in your future quests!  Qiaoli, for all the fun times and various 
names you called me over the board meetings (: Your ambition inspires me. Henna, for your 
kindness, love of art and sports, Hannes, for the lighthearted and unrestricted humour, Elena 
for the delicious cakes, for being so caring and your amazing self. 
Mirco, you have such a gentle heart, thank you for the work you have done for everyone in 
DSA and KI, for being so genuine, supportive and fun. Good luck with your thesis! 
Sebastian, I admire your determination and hard work. Thank you for your practicality, the 
valuable insights and support. I am sure great things wait for you in the future. Marco, I have 
no doubts your hard work will pay off. That mouse trap was enough to convince me you will 
do great in your PhD J Thank your dedication to improve the conditions so other PhDs don’t 
face the same challenges as you did. Yujiao, you can lift the mood of everyone in an instant. 
I am so happy to have met you through DSA. Leonie, for the adorable fun moments and 
valuable input with new angles, Jan, for your effort to make KI a better place, challenging 
discussions and for all the fun we had in Solvik trying not to die from Hantavirus. Valeria, 
for being so kind and considerate. You inspire me with your determination and integrity. 
Good luck on your PhD journey! Amineh, for your hard work, willpower and kindness, it 
has been a pleasure to work with you. Abishek, for being always ready to help. Gabriele, 
for being so meticulous and efficient, your love of cooking and art.  
Åsa, canım benim, yollarımız kesiştiği için çok mutluyum, Bu süreçte içtenliğin ve desteğin 
için tusen tusen tack! Bana her zaman ilham veriyorsun. I admire you for following your 
dreams with such valor. Please always stay as fantastic as you are! Nina, for being so lovely 
and thoughtful, for all your contribution to improve the lives of other people.  
To the first ever BYRS team, to Alca, you can move mountains, I have more words for you 
below J, to Carmen, the incredible mama, your energy is infectious, you are a dream team-
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mate. Thank you for the laughs and the quizzes. Life has so much in store for you and I can’t 
wait to see what you will do next. Olivia, for your passion and drive, to Hanna, Priyanka, 
Anna, Cristina, Linda it was a pleasure to work with each of you and bring this into life. 
Also, to everyone who made it possible, and the wonderful KICC team keeping it alive.  
Karolinska Institutet Career Service (KICS), Anethe (also Emma and Kerstin) for the 
inspiration and support, not least through the KI Career Bloggers community where I get the 
chance to sharpen my pen and mind to share snippets of life with the world, learn from 
Natalie, and be part of an amazing, supportive community.  
Mauricio, it feels like you were my childhood friend even though we grew up oceans away. 
How do I find the words to thank, for being so kind and understanding to hold space when I 
was lost in loss, grief and pain, for always being the voice that reminds me the kinder version 
of the truth, for all the goofy and fun times, karaoke, games, music, the cartoon and memes, 
for ALL your help and support while this thesis was in the making, for being a true friend I 
intend to keep a lifetime.   
Goncalo, Tio patinhas, from the Where is the Waldo pub to today, you have been such a 
precious friend. Thank you for all the fun and laughter, for always listening with open ears 
and tender heart, for your willingness to help everyone you can, for teaching me random 
Portuguese, playing Mario cart, prepping for pubs, your curiosity about other cultures, for 
being such a unifier for your different friend groups, your hilarious sense of humour and for 
never giving up on your dreams. I am sorry that the States will have the privilege to have you 
around, but I have no doubt that you will find yourself a warm place together with Simona, 
and create the home you wish to have. Just remember the Kırmızı Başlıklı Kız once in a 
while.  
Alca, Your kindness, curiosity, genuine interest in other people, all enough to form a strong 
bond immediately. All these years, I knew that I could rely on you if I needed support, an ear 
to listen or have some fun. Thank you for being there for me and for your infectious 
sweetness, for the good times on the dance floor, for teaching me to collect mushrooms, for 
your love of great outdoors, for the shared puppy love. Your I admire you not just as a friend 
but as a scientist too. Your strong passion for science shines through all your work. I feel 
truly lucky to call you a friend and grateful for all your support! Love you and miss you!  
Tomas Matras, for the game nights, mushrooming, our time in the science museum for kids, 
for listening to me whenever I needed to vent, for being such a good friend over these years. 
Jana, for always lifting up the mood and your curiosity and kindness, Milana, for your 
unique humour, big heart and the great Belgrade trip. Theresa for taking care of my office 
plants, your top-notch baking skills and generosity, for your dedication and staying always 
true to yourself, Tom, for organizing football so Jorge can play (:  Sandra, for your never-
ending energy and positivity, for the breathtaking trip to Menorca, for your friendship. 
Joanne, for being the best hiking partner, a great editor and writer, for being a fellow book 
lover and a wonderful friend. Thank you for all the support over these years and for following 
your dreams, Jarda, for your incredible ability to stop muschrooms in the forest, great stories 
and photography, Matthjis and Josi for being the most adorable, nerdy couple I know, 
Matthjis for sharing your love of photography’ electrophysiology and science.  
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Ayla you have such positive energy and drive that brightens everyone’s mood and inspires 
me. Your tenacity can move mountains. Thank you for being unapologetically yourself, for 
writing your own story and choosing courage. Keep moving! Nigel, for your kind and 
thoughtful self, and the laughter. Warms my heart to think about the winter ski conference 
with you two J 
To the crew, who made my almost 10-year-long immigrant tenure bearable. Honestly, I have 
no idea how I would make it without the fun and laughter we shared or without you picking 
me up everytime I fell into the pit.   
Beklem, Bekom, Stockholmun en güzel annesi, kimsemiz olmayan bu yerde birbirimize aile 
olduk. Yeri geldi beni besledin, sırtıma kazak verdin üşümeyeyim diye, acımı paylaştın, 
derdimi dinledin. Kocaman kalbin, güzel yüreğin için, her şey için teşekkür ederim, Seni çok 
seviyorum.Niloş, balböceğim, teyzesinin bir tanesi, neşe kaynağım. Annenin karnından, 
telefonda bana cilve yaptığın günlere geldik. Seni çok seviyorum ve hatıralarımıza 
ekleyeceğimiz yenilerini sabırsızlıkla bekliyorum. Canım Burcum, Karolinska’ya 
geldiğimde herkesin ‘you should meet Burcu’ demesine şaşmamalı, içtenliğin, bulaşıcı ve 
enerji veren kıpır kıpır kahkahan için, benim bütün bu güzel insanlarla tanışmama vesile 
olduğun için, paylaştığımız harika anılar için teşekkürler. Cihan kaptan, müthiş espri 
anlayışın, kayak yoldaşlığın, sıcaklığın ve içtenliğin için teşekkür ederim. The funniest 
couple I know, United Kingdom should feel lucky to borrow you two for a bit. (: 
To the Kamber,  
Özge, çiçeğim, komşum, ne zaman ihtiyacım olsa yardıma koşacağını biliyorum, Stockholm 
bana seni tanıştırdığı için minnettarım. Derdimi dinlediğin, yardım eli uzattığın, umarsızca 
gülüp eğlendiğimiz bütün anlar, kısacası kızkardeşliğin için çok teşekkür ederim. Kerem, 
Burcu’nun mezuniyetinden bugüne dek, seninle ne güzel anılar biriktirdik Keremo, 
midsummer kamp, ski trip, İzmir de bana evsahipliği bile yaptın. Neşeli modun, sosyal 
kelebekliğin, içtenliğin ve inceliğin için çok teşekkür ederim. Daha güzel anılar ufukta. 
İbrahim, the vitlöksås, thank you for being your fantastic colorful self, for all the crazy, 
limitless fun times, your kind and loving heart, countless memories, for always staying true 
to yourself. Onur, for your sense of wonder and exploration, for always being so 
accommodating and caring, for being the atom karınca, you make the best geyik partner!  
Lii, gullis, my favorite Swede, thank you for being your lovely self, for being always caring 
and supportive, for the sister outings, life talks and for all the fun and laughter. Tanya, my 
dear, thank your for your kind and beautiful heart. Hope Stockholm becomes a warm home 
for you. Idil, canım memleketlim, thank you for always being true to yourself, for the a-
mazing mantı and your love of food and books, for making me feel like I’m home, Emelie, 
you are a beautiful and kind human being, the world needs more of you. Uğur, her daim 
ilginç tartışmalarla ve farklı bakış açılarıyla, bilime ve tarihe olan merakınla kattığın herşey 
için teşekkür ederim Uğurcum. Youtube kanalını sonunda hayata geçirmiş olduğun ve benim 
bunda katkım olduğu için de ayrıca minnattarım. Mükemmeliyetçiliğimi challenge ettiğin, 
beni comfort zone dan dışarı çıkardığın için teşekkürler. Reaksiyon rocks. Tubim, canımın 
içi, sigarayı bıraktığın için seninle gurur duyuyorum. Kararlılığın ilham veriyor. David 
kuşuyla bir ömür hep mutlu olun! Tack för alla! Didem, insanın kalbini ısıtan inceliğin ve 
içtenliğin için teşekkür ederim <3 
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Acaba ailesi ve ötesi, kıtalara yayılmış dallara rağmen sapasağlam duran çınar gövdesi 
misali, nerede olursam olayım ailenizin Marslısı bana kendimi evimde hissettirdiniz, 
Gürbüz, my brother from another mother, en güzel goygoy seninle yapılıyor, dert 
paylaşımında numero 1, aşırı karizmatik bir Ediz Hun, burda ne zaman bir arkadaş hakkında 
hikaye anlatsam Gürbüz mü diye soruyorlar. İyi ki gezegenler gezmiş, zangoçlar zangmış, 
kuşlar uçmuş, atlar koşmuş da seninle tanışmışız. Sana bunca yıldır desteğin, paylaştığın 
capsler, insanın ömrünü uzatan geyiklerimiz, kısacası kardeşliğin için nasıl teşekkür etsem 
bilemiyorum. Stockholm ün adalarını saydık beraber, Systembolaget e bile gittik. İyi ki 
varsın, hep var ol Gürb! Didom, canım Doktorum, arım balım peteğim, her zaman kapısı 
çalınabilecek bir dost olduğun için, hepimizin çarpa çarpa öğrendiği şu hayatta yüreğindeki 
çocuksu neşeyi hep koruduğun ve herkese hassasiyetle yaklaştığın, bana evini, sofranı ve 
kollarını açtığın için. Kız kardeşi olmayan bana bir ‘sisterhood’ bahşettiğin ve yürek yeşerten 
inceliğin için, teşekkürler. Aysel teyze ve Mina, ailenizden biriymişimcesine bana kucak 
açtığınız için minnettarım. Umutcan bülbülüm, tee Amerikalardan bugüne, İsveç’te pedal 
çevirdik, düğünlerde kız almalarda halay da çektik, Insbruck’un zirvesine de çıktık seninle. 
Neşen enerjin hiç eksik olmasın, sen de hiç eksik olma, bir ömürlük misafir. Ferritin, başka 
kıtada bile olsam arayıp sorduğun, bunca yıldır bütün o geyikler, muhabbetin, 
kitapseverliğin, düşünceliliğin için teşekkürler. Sen olmasan bu güzel insanlarla 
tanışamazdım muhtemelen, onun için ayrıca müteşekkirim. Fevzi her zaman başka bir açıdan 
bakarak tartışmayı zenginleştirdiğin için, Atatürk Liseliler arasındaki diğer İYTEli 
dayanışması için, bilime olan inancın ve açık fikirliliğin için, Pınpın ve Özgün, ballı lokma 
tatlıları, içtenliğiniz ve paylaştığımız güzel anılar için, Pınar-İrfan, bana evinizin kapısını 
açtığınız için, Pınar mektup arkadaşlığımız, seninle hiç düşünmeden herşeyi paylaşabilğim 
ve yargısız her halime alan tanıdığın, bazen sözlere ihtiyaç durmadan anladığın, eşsiz 
yoldaşlığın için, Beste, balım, cesaretin ve heyecanın müthiş ilham veriyor. Kocaman 
yüreğin, kitap ve hayvan sevgin, beni yollara teşvik ettiğin, yollarda bana eşlik ettiğin için 
teşekkürler.  
Sema, yavrucağım, IYTEnin bozkırlarından, Urla dolmuşlarına, Bornova sokaklarına, 
okyanuslara rağmen, yıllarla yollarla yürek yangınlarıyla test edilmiş onaylanmış 
dostluğumuzun benzerine yedi cihanda rastlamadım. Canım! Teşekkür ederim.  
Tüm aileme, büyüklere ve minnoşlara, teşekkürler. Tek tek saysam sayfalar yetmez, hepinizi 
seviyorum. İyi ki varsınız. 
To my mom, Annem, Sana sayfalarca kitaplarca teşekkür kafi kalabilir mi hiç? Beni 
bugünlere getirirken harcadığın tüm emekler için sonsuz teşekkürler. Seni çok seviyorum.  
Sezgin, canım abim, elinden tutup yürümeyi öğrettiğin minik kız umarım seni 
gururlandırmıştır. Seni çok seviyorum ve bugüne dek hiç eksik olmayan desteğin için çok 
teşekkür ederim. Sana sevdiceğinle mutluluk ve huzur diliyorum. Tez zamanda kavuşmayı 
hayal ediyorum.   
Berna, kıvır kıvır kıpır kıpır bacım, iyi ki ailemize dahil oldun, enerjin ve neşen hiç 
eksilmesin, her şey için çok teşekkür ederim! Sinem, I admire you and your beautiful heart! 
Your kindness, compassion and understanding for other people make this world a much better 
 
 49 
place. With its ups and downs, you are steadfast and ready to take on life, please keep living 
the life to the fullest as you do and stay as your fabulous self.  
To Team Correia: Manuel, Maria Fernanda, Isabel, David, muito obrigada por tudo! 
Sefa, kıvırcığım, diğer yarım, yazımın sıcağı, kışımın ocağı, her şeyden kıymetlim. Binlerce 
kilometre mesafeye ragmen her daim yanımda olduğunu hissettirdiğin için teşekkür ederim. 
Seni düşündükçe gururla dolup taşıyor kalbim, keşke bugün burda benimle olabilseydin. 
Yine sana sarılacağım günü iple çekiyorum. Seni hayal edebileceğinden daha çok seviyorum. 
Baba, I wish you were here to see me today. Ne zaman bitecek diye soruyordun, bugün bitti 
baba. Hassas kalbin, öğrettiğin hersey icin ne kadar teşekkür etsem kafi gelmez. Umarım 
gittiğin yerde oltan ve karideslerinle taze balıklar tutuyor, bizi gururla seyrediyorsundur.  
Hep aklımdasın. 
 
To Jorge Miguel the sincap,    
I would have never achieved this without being wrapped around your support, care and love. 
In every step of the way, you held my hand so firmly, guided me if necessary and reminded 
me what matters the most. For that, I am eternally grateful.  
“Love doesn't just sit there, like a stone, it has to be made, like bread; remade all the time, 
made new.” I am incredibly lucky to have you, as we hold onto each other for all that is to 
come. Thank you for all the memories we made during this part of our lives, and I cannot 
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